Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
====================================================================================================================================================================================================================================================================================

* Jason Chesney
* Karl D Lewis
* Harriet Kluger
* Omid Hamid
* Eric Whitman
* Sajeve Thomas
* Martin Wermke
* Mike Cusnir
* Evidio Domingo-Musibay
* Giao Q Phan
* John M Kirkwood
* Jessica C Hassel
* Marlana Orloff
* James Larkin
* Jeffrey Weber
* Andrew J S Furness
* Nikhil I Khushalani
* Theresa Medina
* Michael E Egger
* Friedrich Graf Finckenstein
* Madan Jagasia
* Parameswaran Hari
* Giri Sulur
* Wen Shi
* Xiao Wu
* Amod Sarnaik